RenovoRx Financials - Benzinga

RenovoRx Inc

RNXTNASDAQ

Trade with Public

Trade with Public

$1.94

0.010.52%

Last update: Sep 1, 9:28 AM

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

RenovoRx Financials

RenovoRx (RNXT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
RenovoRx Raises FY2026 Sales Guidance from $3.000M-$4.000M to $3.750M-$4.250M vs $3.203M Est

RenovoRx (NASDAQ:RNXT) raises FY2026 sales outlook from $3.000 million-$4.000 million to $3.750 million-$4.250 million vs $3.203 million estimate.

Benzinga Newsdesk

PRO
RenovoRx Q2 Adj. EPS $(0.05) Beats $(0.07) Estimate, Sales $909.000K Beat $716.500K Estimate

RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 37.5 percent increase over losses of $(0.08) per share from the same

Benzinga Newsdesk

PRO
RenovoRx Affirms FY2026 Sales Guidance of $3.000M-$4.000M vs $3.244M Est.

RenovoRx (NASDAQ:RNXT) affirms FY2026 sales outlook from $3.000 million-$4.000 million to $3.000 million-$4.000 million vs $3.244 million estimate.

Benzinga Newsdesk

PRO
RenovoRx Q1 Adj. EPS $(0.08), Inline, Sales $563.000K Beat $463.250K Estimate.

RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 14.29 percent decrease over losses of $(0.07) per share from the same period last year. The

Benzinga Newsdesk

Earnings Scheduled For May 14, 2026

Benzinga Insights

PRO
RenovoRx Q4 EPS $(0.08), Inline, Sales $238.000K Miss $419.750K Estimate

RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 33.33 percent increase over losses of $(0.12) per share from the same period last year. The

Benzinga Newsdesk